Efficacy and safety of weekly paclitaxel combined with cetuximab in the treatment of pretreated recurrent/metastatic head and neck cancer patients

Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) Program

Matthew J. Hayat, Nadia Howlader, Marsha E. Reichman et al. · The Oncologist · 2007 · 1.1K citations · Full text

Medicine, Biostatistics, Oncology +17

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy

Jan B. Vermorken, José Trigo, Ricardo Hitt et al. · Journal of Clinical Oncology · 2007 · 1K citations · Full text

Medicine, Oncology, Pharmacology +16

Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck

José Baselga, José Trigo, Jean Bourhis et al. · Journal of Clinical Oncology · 2005 · 491 citations

Medicine, Oncology, Chemotherapy +13

Phase II Multicenter Study of the Epidermal Growth Factor Receptor Antibody Cetuximab and Cisplatin for Recurrent and Refractory Squamous Cell Carcinoma of the Head and Neck

Roy S. Herbst, Matthew A. Arquette, Dong M. Shin et al. · Journal of Clinical Oncology · 2005 · 402 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

The Effects of Cetuximab Alone and in Combination With Radiation and/or Chemotherapy in Lung Cancer

David Raben, B. Helfrich, Daniel C. Chan et al. · Clinical Cancer Research · 2005 · 241 citations

Medicine, Oncology, Pharmacology +17